02 Jun. 2014
WILMINGTON, N.C. (June 2, 2014) – Pharmaceutical Product Development, LLC (PPD) today announced it has been selected as one of the most innovative organizations using information technology to create business value by CIO magazine’s 27th annual CIO 100 Awards.
PPD earned recognition for PreclarusTM, its comprehensive technology solution that delivers real-time data and dynamic analytics to enable effective decision-making in clinical research. Preclarus consolidates large amounts of clinical trial data and allows clients to explore data more quickly and generate deeper insights to guide the research process.
“The increasing intelligence made possible with real-time data and robust analytics is evolving and enhancing the conduct of clinical trials,” said Mike Wilkinson, executive vice president and chief information officer of PPD. “Preclarus supports cutting-edge research, such as adaptive trial designs and PPD’s adaptive and intelligent approach to risk-based monitoring, which is changing the way clinical teams perform their jobs, while maintaining high quality and close oversight of clinical trial sites.”
Combining the use of analytical data reports with efficient processes for turning those reports into actionable findings, Preclarus provides early recognition of trends, early identification of risks, and more immediate, effective decisions and actions to improve study quality and efficiency. Preclarus dashboards offer real-time, interactive visualizations and analytics that allow users to drill down into data for detailed information.
“The advantage of Preclarus is that it’s not simply industry-leading technology, but rather a robust combination of our process, people and organization behind the data,” said Paul Colvin, PPD’s executive vice president, global clinical development. “Preclarus is a powerful tool providing data integration, predictive analytics, transparency and an unprecedented reporting scope, giving PPD clients actionable data at their fingertips to inform critical decision-making for successful clinical trials.”
PPD will accept the award during the CIO 100 Symposium & Awards Ceremony, Aug. 17-19, in Rancho Palos Verdes, California, and will be featured in the Aug. 1 issue of CIO magazine.
PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
+1 919 456 5350
+1 910 558 7585